From CBD to THCV: Clinical Trials & ECS Brands

ECS Brands has received support from the NIH and guidance from the Mayo Clinic to assess THCV in clinical trials. In this article, Aaron Green interviews Arthur Jaffee, Founder & CEO of ECS Brands to learn more about their recent clinical safety trial involving cannabinoids.

The post From CBD to THCV: Clinical Trials & ECS Brands appeared first on Cannabis Industry Journal.